Redistribution of fibroblasts and macrophages as micrometastases develop into established liver metastases.
Fibroblastic tissue is an important component of malignant tumors, involved in the establishment of metastatic foci from micrometastases, and thought to prevent invasion of metastatic tumor cells into surrounding tissue. However, experimental models of fibrosis during the growth of micrometastasis into established metastases were not previously available. In the present paper, we performed immunohistochemical studies on experimental hepatic metastasis with colon 38 mouse colon carcinoma cells injected into syngeneic C57BL/6 mice. Early and late stages of metastatic nodules were examined for the distribution of endothelial cells, fibroblasts, and macrophages by the use of markers of these cells. One week after intrasplenic injection of colon 38 cells, micrometastases mainly appeared in the region of sinusoids accompanied with invasion of F4/80-positive Kupffer cells. Transitional metastases can be defined based on the histological appearance and intensive infiltration of both macrophages and fibroblasts. These transitional metastases were connected by protrusions of fibroblast-rich tissues co-localized with collagen-rich matrix and CD31-positive cells. This protrusion preceded fibrosis formation characteristics to established metastases associated with angiogenesis and segregation of tumor cells from host cells. Three stages can thus be classified during the development of hepatic metastasis in this syngeneic experimental system: micrometastasis, transitional metastasis, and established metastasis.
Higashi
Nobuaki
N
Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Ishii
Hideki
H
Fujiwara
Takeshi
T
Morimoto-Tomita
Megumi
M
Irimura
Tatsuro
T
D000230:Adenocarcinoma / Q000473:pathology / Q000556:secondary*; D000818:Animals; D000943:Antigens, Differentiation / Q000378:metabolism; D001212:Asialoglycoproteins; D003110:Colonic Neoplasms / Q000473:pathology; D004727:Endothelium / Q000473:pathology; D005260:Female; D005347:Fibroblasts / Q000473:pathology*; D037181:Lectins, C-Type / Q000378:metabolism; D008103:Liver Cirrhosis / Q000473:pathology; D008113:Liver Neoplasms / Q000473:pathology* / Q000556:secondary*; D008264:Macrophages / Q000378:metabolism / Q000473:pathology*; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL
D000943:Antigens, Differentiation; D001212:Asialoglycoproteins; C064720:Clec10a protein, mouse; D037181:Lectins, C-Type; D008565:Membrane Proteins; C036763:monocyte-macrophage differentiation antigen